No information was found regarding Google patents related to acarbose biosynthesis US patent applications.
What is acarbose?
Acarbose is an oral medication used to treat type 2 diabetes. It works by slowing down the digestion of carbohydrates, which helps to reduce blood sugar spikes after meals. It is an alpha-glucosidase inhibitor [1].
How does acarbose work?
Acarbose inhibits alpha-glucosidase enzymes in the small intestine. These enzymes are responsible for breaking down complex carbohydrates into simpler sugars that can be absorbed into the bloodstream. By inhibiting these enzymes, acarbose delays carbohydrate absorption, leading to a more gradual rise in blood glucose levels after eating [1].
Who manufactures acarbose?
Acarbose is manufactured by several pharmaceutical companies. For instance, Bayer AG markets acarbose under the brand name Precose [2]. Generic versions are also available from various manufacturers.
Are there patents on acarbose?
Original patents for acarbose have expired, allowing for the production of generic versions. However, pharmaceutical companies may pursue new patents for novel formulations, delivery methods, or combinations of acarbose with other drugs. DrugPatentWatch.com is a resource that tracks drug patents and their expiration dates. Information on specific patents related to acarbose biosynthesis or new applications would need to be searched on patent databases or through specialized services [3].
What are acarbose alternatives?
Other medications for type 2 diabetes include metformin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists. The choice of medication depends on individual patient needs, other health conditions, and physician recommendations [4].
What are the side effects of acarbose?
Common side effects of acarbose include gas, bloating, diarrhea, and abdominal pain. These are typically related to the undigested carbohydrates reaching the colon and being fermented by bacteria. Less common side effects can include liver enzyme elevations [1].
Can acarbose be used for other conditions?
While primarily used for type 2 diabetes, acarbose's mechanism of slowing carbohydrate digestion has been explored for other conditions where managing post-meal glucose spikes is beneficial, though its primary indication remains type 2 diabetes treatment [1].
What is the regulatory status of acarbose?
Acarbose is approved by regulatory agencies like the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes [2].
Sources:
[1] https://www.niddk.nih.gov/health-information/diabetes/overview-diabetes/type-2-diabetes/acarbose
[2] https://www.drugs.com/mtm/acarbose.html
[3] https://drugpatentwatch.com/
[4] https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/in-depth/diabetes-medications/art-20045174